24 research outputs found

    Failure to recognize Low non-treponemal titer syphilis infections in pregnancy May lead to widespread under-treatment

    Get PDF
    Objectives: Rates of maternal syphilis have increased five-fold in Brazil in the past decade. While penicillin remains the only appropriate treatment for maternal syphilis, we hypothesized that low non-treponemal titers (<1:16) may lead to reduced penicillin treatment in Brazil. Methods: Using Brazilian Ministry of Health data on women diagnosed with maternal syphilis between January 1, 2010, and December 31, 2018, we conducted a random-effects logistic regression model with a cluster correction at the state level to evaluate predictive factors of penicillin treatment. Results: We observed yearly increases in cases of pregnant women with syphilis from 2010 to 2018. There was significant variation by state: 52,451 cases were reported in São Paulo, followed by 26,838 in Rio de Janeiro. Among 215,937 cases of maternal syphilis, 91·3% received penicillin. In the random-effects model, a non-treponemal titer ≥1:16 was associated with 1·44 higher odds of receiving penicillin (95% confidence interval [CI]: 1·391·48), and prenatal care was associated with a 2·12 increased odds of receiving penicillin (95% CI: 2·022·21). Although there is an association between the absence of prenatal care and inadequate treatment for syphilis, 83·2% of women in this cohort who did not receive penicillin were engaged in prenatal care. Conclusions: Providers may inappropriately exclude low non-treponemal titers and thereby fail to use penicillin treatment in maternal syphilis. While the cause of the maternal syphilis epidemic in Brazil is multifactorial, we believe our findings can be used to develop targeted interventions throughout Brazil as well as shape public health initiatives globally.National Institute of Mental HealthRevisión por pare

    Intersection of COVID-19, HIV and exercise: a commentary with home-based exercise recommendations for practice.

    No full text
    The worldwide spread of COVID-19 has led to closures or reduced capacity of non-essential businesses and recreational areas and stay-at-home orders to promote social distancing. Although effective to reduce transmission, these policies may negatively impact exercise behaviors. Exercise is effective at mitigating the risk of developing or exacerbating several of underlining risk factors for a more severe COVID-19 disease course and may be particularly important for people with HIV (PWH). In this commentary, we discuss the intersection of COVID-19 and exercise with a specific focus on people living with HIV. We then provide a pragmatic, home-based exercise routine that can be performed with little to no equipment or supervision. It is important for PWH (and others) to start or maintain at least some level of exercise to reduce the risk of a severe COVID-19 disease course and to improve other health outcomes in this unfamiliar climate

    Dual rapid lateral flow immunoassay fingerstick wholeblood testing for syphilis and HIV infections is acceptable and accurate, Port-au-Prince, Haiti.

    No full text
    BackgroundDual rapid tests for HIV and syphilis infections allow for detection of HIV infection&nbsp;and syphilis at the point-of-care. Those tests have been evaluated in laboratory settings and show excellent performance but have not been evaluated in the field. We evaluated the field performance of the SD BIOLINE HIV/Syphilis Duo test in Port-au-Prince, Haiti using whole blood fingerprick specimens.MethodsGHESKIO (Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections) clinic attendees 18&nbsp;years of age or older were invited to participate. Venipuncture blood specimens were used for reference testing with standard commercially available tests for HIV and syphilis in Haiti. The sensitivity and specificity of the Duo test compared to the reference standard were calculated. The exact binomial method was used to determine 95&nbsp;% confidence intervals (CI).ResultsOf 298 study participants, 237 (79.5&nbsp;%) were female, of which 49 (20.7&nbsp;%) were pregnant. For the HIV test component, the sensitivity and specificity were 99.2&nbsp;% (95&nbsp;% CI: 95.8&nbsp;%, 100&nbsp;%) and 97.0&nbsp;% (95&nbsp;% CI: 93.2&nbsp;%, 99.0&nbsp;%), respectively; and for the syphilis component were 96.5&nbsp;% (95&nbsp;% CI: 91.2&nbsp;%, 99.0&nbsp;%) and 90.8&nbsp;% (95&nbsp;% CI: 85.7&nbsp;%, 94.6&nbsp;%), respectively. In pregnant women, the sensitivity and specificity of the HIV test component were 93.3&nbsp;% (95&nbsp;% CI: 68.0&nbsp;%, 99.8&nbsp;%) and 94.1&nbsp;% (95&nbsp;% CI: 80.3&nbsp;%, 99.3&nbsp;%), respectively; and for the syphilis component were 100&nbsp;% (95&nbsp;% CI:81.5&nbsp;%, 100&nbsp;%) and 96.8&nbsp;% (95 % CI:83.3&nbsp;%, 99.9&nbsp;%), respectively.ConclusionThe Standard Diagnostics BIOLINE HIV/Syphilis Duo dual test performed well in a field setting in Haiti and should be considered for wider use
    corecore